Evidence-Based Complementary and Alternative Medicine / 2019 / Article / Tab 2

Research Article

Four Subgroups of Blood Stasis Syndrome Are Identified by Manifestation Cluster Analysis in Males

Table 2

Differences in the biological parameters between the redefined non-BSS and BSS subgroups.

non-BSSBSS
No.Biologic parameter, median (Q1-Q3)non-BSS(1)BSS(1)BSS(2)BSS(3)BSS(4)
(n = 90)(n = 27)(n = 13)(n = 25)(n = 31)

1RBC (106/μL)4.77 (4.52-5.04)4.77 (4.48-5.02)4.92 (4.65-5.08)4.5 (4.13-4.82)4.85 (4.51-5.26)
2Hb (g/dL)14.7 (14.2-15.5)14.8 (14.1-15.6)14.9 (14.7-15.5)14 (12.3-14.9)15.3 (14.3-16.3)
3Hct (%)44.15 (41.6-45.7)44 (41.9-46.1)43.7 (42.8-46.1)42.7 (39.4-44.8)45.7 (42-46.9)
4MCV (fL)92.35 (90-94.5)91.7 (89.1-94.7)91 (90-94.6)92.9 (89.7-96.5)92.1 (89.5-94)
5MCH (pg)31.1 (30.3-31.9)31.4 (30.1-31.7)31.2 (30.7-31.3)31.1 (29.9-32.2)31.3 (30.5-32)
6MCHC (%)33.8 (33-34.4)33.9 (33.3-34.4)33.8 (33.4-34.8)33.3 (32.5-34)34 (33.5-34.5)
7RDW (%)12.8 (12.5-13.3)12.9 (12.5-13.3)12.9 (12.7-13.3)13.4 (12.6-14.2)12.9 (12.4-13.3)
8Platelet (106/μL)223.5 (185-253)234 (216-275)227 (193-280)22.8 (188-264)23.8 (215-263)
9MPV (fL)10.7 (10.2-11.3)10.3 (10-11)10.7 (10.3-11.1)10.6 (10.2-11)10.9 (10.2-11.6)
10PDW (%)12.05 (11.1-13.1)11.1 (10.8-12.4)11.9 (11.1-12.8)11.9 (10.7-12.7)12.4 (11.1-14.1)
11WBC (103/μL)5.37 (4.68-6.62)5.71 (4.66-7.27)5.53 (4.36-7.21)6.62 (6.15-7.93)6.56 (5.95-8.19)
12Neutrophil (%)51.55 (48.6-58.5)52.5 (47.2-57.4)48.8 (44.8-55.1)59.4 (53.7-64.3)57.5 (52.6-62.9)
13Lymphocyte (%)35.8 (29.6-40.5)36.3 (31.2-39.8)41.9 (37.2-46.3)30 (24.1-37.1)30.1 (25.3-34.2)
14Monocyte (%)7.15 (6.3-8.8)7.7 (6.6-8.7)7.8 (5.7-8.7)7.2 (6.2-10)7.4 (6.2-9.2)
15Eosinophil (%)2.5 (1.9-4.6)2.5 (1.5-5.1)2.6 (0.9-4.3)2.1 (1.2-3.4)2.3 (1.6-4.5)
16Creatinine (mg/dL)0.93 (0.85-1.03)0.9 (0.86-0.98)0.91 (0.85-1)0.89 (0.82-0.95)0.9 (0.85-0.98)
17BUN (mg/dL)13 (11.4-15.3)14.2 (13-16.8)11.9 (10.4-15.4)11.6 (9.5-15.3)13.9 (11.5-16.7)
18Total protein (g/dL)7.02 (6.68-7.31)7.02 (6.7-7.25)7.15 (6.87-7.27)6.84 (6.52-7.12)7.04 (6.67-7.29)
19Total cholesterol (mg/dL)169.5 (149-206)174 (151-210)172 (150-187)174 (155-186)169 (161-197)
20HDL(mg/dL)49.7 (39.9-59.1)46.3 (40.7-56.8)46.3 (32.4-53.9)43.2 (34-55.7)45.5 (39-53.6)
21Triglyceride (mg/dL)136.5 (89-201)133 (91-218)165 (127-286)150 (104-246)153 (109-200)
22Total lipid (mg/dL)485.5 (422-581)486 (454-614)525 (443-619)520 (437-567)487 (422-598)
23AST (IU/L)19 (16-23)19 (17-26)23 (21-25)21 (16-23)21 (18-29)
24ALT (IU/L)18.5 (14-25)21 (16-34)27 (20-28)20 (15-26)25 (16-31)
25ALP (IU/L)63.5 (54-71)63 (57-80)61 (54-69)73 (61-81)60 (54-73)
26Total bilirubin (mg/dL)0.39 (0.3-0.56)0.44 (0.26-0.6)0.41 (0.36-0.54)0.38 (0.23-0.57)0.43 (0.3-0.59)
27Direct bilirubin (mg/dL)0.19 (0.13-0.25)0.18 (0.12-0.23)0.19 (0.14-0.24)0.18 (0.11-0.22)0.17 (0.13-0.24)
28Indirect bilirubin (mg/dL)0.2 (0.15-0.31)0.2 (0.14-0.4)0.2 (0.14-0.32)0.18 (0.12-0.38)0.25 (0.17-0.35)
29Albumin (g/dL)4.5 (4.33-4.7)4.44 (4.32-4.7)4.6 (4.44-4.74)4.3 (4.14-4.53)4.43 (4.29-4.6)
30Globulin (g/dL)2.51 (2.32-2.71)2.47 (2.29-2.74)2.45 (2.41-2.55)2.52 (2.35-2.67)2.52 (2.29-2.71)
31A/G ratio1.8 (1.66-1.99)1.83 (1.64-.1.94)1.86 (1.79-1.99)1.75 (1.55-1.82)1.81 (1.61-1.93)
32Fibrinogen (mg/dL)256 (218-307)247 (216-289)239 (203-287)281 (222-339)276 (246-348)
33D-dimer (μg/mL)0.2 (0.2-0.2)0.2 (0.2-0.3)0.2 (0.2-0.2)0.3 (0.2-0.6)0.2 (0.2-0.3)
34CRP (mg/L)0.5 (0.3-1.1)0.5 (0.3-1.5)0.6 (0.4-1)1.7 (0.4-8.4)0.7 (0.4-1.7)

A bold font represents a P value < 0.01 compared to the non-BSS(1) group using Wilcoxon Rank Sum test. RBC: red blood cell; Hb: hemoglobin; Hct: hematocrit; WBC: white blood cell; CRP: C-reactive protein.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.